These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 10845688)

  • 21. Effect of vesicle size on in vivo release of daunorubicin from hydrogenated egg phosphatidylcholine-based liposomes into blood circulation.
    Nagayasu A; Shimooka T; Kiwada H
    Biol Pharm Bull; 1995 Jul; 18(7):1020-3. PubMed ID: 7581243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of preparation method and cholesterol on drug encapsulation studies by phospholipid liposomes.
    Cagdas FM; Ertugral N; Bucak S; Atay NZ
    Pharm Dev Technol; 2011 Aug; 16(4):408-14. PubMed ID: 20433249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kanamycin incorporation in lipid vesicles prepared by ethanol injection designed for tuberculosis treatment.
    Justo OR; Moraes AM
    J Pharm Pharmacol; 2005 Jan; 57(1):23-30. PubMed ID: 15638989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dexamethasone incorporating liposomes: effect of lipid composition on drug trapping efficiency and vesicle stability.
    Tsotas VA; Mourtas S; Antimisiaris SG
    Drug Deliv; 2007 Oct; 14(7):441-5. PubMed ID: 17994361
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High efficiency entrapment of superoxide dismutase into mucoadhesive chitosan-coated liposomes.
    Galović Rengel R; Barisić K; Pavelić Z; Zanić Grubisić T; Cepelak I; Filipović-Grcić J
    Eur J Pharm Sci; 2002 Jun; 15(5):441-8. PubMed ID: 12036721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gelation of the internal core of liposomes as a strategy for stabilization and modified drug delivery I. Physico-chemistry study.
    Petralito S; Paolicelli P; Nardoni M; Trilli J; Di Muzio L; Cesa S; Relucenti M; Matassa R; Vitalone A; Adrover A; Casadei MA
    Int J Pharm; 2020 Jul; 585():119467. PubMed ID: 32497730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Membrane interactions of ternary phospholipid/cholesterol bilayers and encapsulation efficiencies of a RIP II protein.
    Manojlovic V; Winkler K; Bunjes V; Neub A; Schubert R; Bugarski B; Leneweit G
    Colloids Surf B Biointerfaces; 2008 Jul; 64(2):284-96. PubMed ID: 18359207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction of lipoprotein lipase with phospholipid vesicles: effect on protein and lipid structure.
    McLean LR; Larsen WJ; Jackson RL
    Biochemistry; 1986 Feb; 25(4):873-8. PubMed ID: 3964650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liposome-encapsulated midazolam for oral administration.
    Tomoyasu Y; Yasuda T; Maeda S; Higuchi H; Miyawaki T
    J Liposome Res; 2011 Jun; 21(2):166-72. PubMed ID: 20684674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of electrolyte on the encapsulation efficiency of vesicles formed by the nonionic surfactant, 2C18E12.
    Harvey RD; Barlow DJ; Drake AF; Kudsiova L; Lawrence MJ; Brain AP; Heenan RK
    J Colloid Interface Sci; 2007 Nov; 315(2):648-61. PubMed ID: 17692324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5-Fluorouracil in topical liposome gels for anticancer treatment--formulation and evaluation.
    Glavas-Dodov M; Fredro-Kumbaradzi E; Goracinova K; Calis S; Simonoska M; Hincal AA
    Acta Pharm; 2003 Dec; 53(4):241-50. PubMed ID: 14769231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction of liposome with immobilized chitosan during main phase transition.
    Fang N; Chan V
    Biomacromolecules; 2003; 4(3):581-8. PubMed ID: 12741773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
    Hadinoto K; Sundaresan A; Cheow WS
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanism of cholesterol and phosphatidylcholine exchange or transfer between unilamellar vesicles.
    McLean LR; Phillips MC
    Biochemistry; 1981 May; 20(10):2893-900. PubMed ID: 7195733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of processing variables on the physical characteristics of non-ionic surfactant vesicles (niosomes) formed from a hexadecyl diglycerol ether.
    Arunothayanun P; Bernard MS; Craig DQ; Uchegbu IF; Florence AT
    Int J Pharm; 2000 May; 201(1):7-14. PubMed ID: 10867260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phospholipid vesicles as carriers in aquaculture: preparation and stability study of thiamine hydrochloride-loaded liposomes.
    Lai F; Valenti D; Sinico C; Manconi M; Mendez JB; Fadda AM
    Curr Drug Deliv; 2004 Apr; 1(2):145-52. PubMed ID: 16305380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chitosan-coated nanoliposome as vitamin E carrier.
    Liu N; Park HJ
    J Microencapsul; 2009 May; 26(3):235-42. PubMed ID: 18798045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A targeted liposome delivery system for combretastatin A4: formulation optimization through drug loading and in vitro release studies.
    Nallamothu R; Wood GC; Kiani MF; Moore BM; Horton FP; Thoma LA
    PDA J Pharm Sci Technol; 2006; 60(3):144-55. PubMed ID: 17089683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of drug release from liposomal formulations in ocular fluid.
    Jafari MR; Jones AB; Hikal AH; Williamson JS; Wyandt CM
    Drug Deliv; 1998; 5(4):227-38. PubMed ID: 19569989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stability of SUV liposomes in the presence of cholate salts and pancreatic lipases: effect of lipid composition.
    Kokkona M; Kallinteri P; Fatouros D; Antimisiaris SG
    Eur J Pharm Sci; 2000 Jan; 9(3):245-52. PubMed ID: 10594380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.